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Abstract
Background: Human exercise capacity declines with advancing age. These changes often result in loss of physical 
fitness and more rapid senescence. Nitric oxide (NO) has been implicated in improvement of exercise capacity through 
vascular smooth muscle relaxation in both coronary and skeletal muscle arteries, as well as via independent 
mechanisms. Antioxidants may prevent nitric oxide inactivation by oxygen free radicals. The purpose of this study was 
to investigate the effects of an L-arginine and antioxidant supplement on exercise performance in elderly male cyclists.
Methods: This was a two-arm prospectively randomized double-blinded and placebo-controlled trial. Sixteen male 
cyclists were randomized to receive either a proprietary supplement (Niteworks®, Herbalife International Inc., Century 
City, CA) or a placebo powder. Exercise parameters were assessed by maximal incremental exercise testing performed 
on a stationary cycle ergometer using breath-by-breath analysis at baseline, week one and week three.
Results: There was no difference between baseline exercise parameters. In the supplemented group, anaerobic 
threshold increased by 16.7% (2.38 ± 0.18 L/min, p < 0.01) at week 1, and the effect was sustained by week 3 with a 
14.2% (2.33 ± 0.44 L/min, p < 0.01). In the control group, there was no change in anaerobic threshold at weeks 1 and 3 
compared to baseline (1.88 ± 0.20 L/min at week 1, and 1.86 ± 0.21 L/min at week 3). The anaerobic threshold for the 
supplement groups was significantly higher than that of placebo group at week 1 and week 3. There were no 
significant changes noted in VO2 max between control and intervention groups at either week 1 or week 3 by 
comparison to baseline.
Conclusion: An arginine and antioxidant-containing supplement increased the anaerobic threshold at both week one 
and week three in elderly cyclists. No effect on VO2 max was observed. This study indicated a potential role of L-arginine 
and antioxidant supplementation in improving exercise performance in elderly.
Introduction
Human exercise capacity declines with advancing age and
many individuals lose the inclination to participate in reg-
ular physical activity. These changes often result in loss of
physical fitness and more rapid senescence. A dietary
supplement that increases exercise capacity might pre-
serve physical fitness and improve general health and well
being in older humans.
Endothelial nitric oxide synthase (eNOS) uses the
amino acid L-arginine as a substrate to synthesize nitric
oxide (NO). When released from endothelium cells, NO
can dilate arteries to increase blood flow [1], help main-
tain endothelial elasticity [2], prevent platelets from
adhering to artery walls [3], mediate erections through
smooth muscle relaxation [4], and increase capacity for
exercise [5]. In addition, NO can play an integral part in
the immune system [6], assist in memory function [7] and
sleep regulation [8]. It should also be noted that in gen-
eral, youthful, healthy and athletic individuals have a
healthier eNOS system, compared to sedentary,
unhealthy and aging individuals [9]. A healthy NO and
vascular system facilitates the healthy function of arteri-
oles that mediate oxygen delivery to multiple organs and
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tissues, including the muscles and kidneys that may
impact exercise performance [10].
NO production diminishes in quantity and availability
as we age and is associated with an increased prevalence
of other cardiovascular risk factors [11]. Hypertension
has been shown to promote premature aging of the
endothelial system in humans [11]. In individuals with
cardiovascular risk factors including hypertension,
hypercholesterolemia, smoking, diabetes, obesity, insulin
resistance, erectile dysfunction, and metabolic changes
associated with aging, supplementation with arginine has
been shown to improve NO-dependent endothelial relax-
ation [12], and improving age-associated endothelial dys-
function [13].
Antioxidants may prevent nitric oxide inactivation by
oxygen free radicals. For example, Vitamin C has been
shown to improve impaired endothelial vasodilation in
essential hypertensive patients, and effect that can be
reversed by the nitric oxide synthase inhibitor NG-
monomethyl-L-arginine[14]. There is also research indi-
cating that the combination of vitamin C, vitamin E (1.0%
to water) and L-arginine works synergistically to enhance
nitric oxide production, through nitric oxide synthase
gene expression[15]. A study in Atherosclerosis showed
Vitamin E (1000 IU/day) improved endothelium health
and increased eNOS expression in hypercholesterolemic
subjects [16].
Therefore, the present study was designed to extend the
above observations by testing the hypothesis that argin-
ine and antioxidants in combination would enhance per-
formance as indicated by objective measures in a
prospectively randomized, placebo-controlled trial in
elderly cyclists.
Methods
Human subjects
The experimental protocol was approved by the Institu-
tional Review Board at the University of California, Los
Angeles. All subjects were informed of the potential risks,
benefits, and time requirements prior to signing a written
informed consent.
Sixteen male cyclists were recruited to participate in
the study through a cycling club in the West Los Angeles
area. Men between the ages of 50 and 73 who performed
at least 4 hours per week of moderate to intense cycling
were screened for this study. Key exclusion criteria
included smoking, a history of coronary heart disease,
morbid obesity (BMI > 40), or any prior or current medi-
cal problems that would limit the subject's physical per-
formance. The participants were apparently healthy and
free of any significant medical problems. They were also
not taking any medications that impact eNOS system, or
other sports enhancing supplementations during the time
of the study.
Study design
This was a three-week, randomized, double-blinded, pla-
cebo-controlled clinical intervention trial. During the
screening visit, a history and a physical examination were
performed. Baseline blood tests including a complete
blood count, a routine chemistry panel, and a measure-
ment of cholesterol were also obtained. All subjects
underwent baseline exercise testing. If the subjects
showed any evidence of ischemic heart disease based on
EKG criteria, pulmonary or musculoskeletal diseases that
prevented them from finishing the test, they were
excluded from the study. If subjects qualified for the
study, they were randomized to either the placebo or the
supplementation group in a 1:1 ratio. The supplementa-
tion began at week 0 after the baseline exercise testing.
The subjects returned to the study center at week 1 and
week 3 for further exercise testing.
Performance Assessment
At the initial screening visit, aerobic capacity and physical
fitness were assessed by measuring maximal oxygen
uptake (VO2max) and the gas exchange anaerobic thresh-
old (VO2θ) during a symptom limited, incremental work
rate exercise test, targeted to last between 8 to 12 min-
utes. Screening allowed for determination of whether the
subject was physically fit to complete the study, could tol-
erate the experimental setup (including breathing
through the mouthpiece), and permitted the subject to
accustom to the study protocol. On subsequent visits,
exercise endurance was assessed by measuring time to
exhaustion at 60% of the maximal work rate achieved
during the initial incremental work rate exercise test,
with a targeted duration of testing between 45 minutes
and 1 hour.
Incremental Work Rate Exercise Test (IWR) for VO2max
Maximal exercise performance was assessed using a
symptom-limited incremental exercise protocol on a
cycle ergometer [Ergoline 900S; Sensormedics Corp,
Loma Linda, CA]. The external work rate was continu-
ously incremented in "ramp" fashion by computer con-
trol. The rate of incrementation was judged for each
individual subject by considering age, gender, height,
weight, and level of habitual exercise activity with the
intention of obtaining an exercise phase of 8-12 minutes
before exhaustion [17]. The increment in resistance for
baseline test and two subsequent tests for each subject
was consistent.
Minute ventilation was measured using a mass flow
meter; expired fractional concentrations of oxygen and
carbon dioxide were continuously monitored by a para-
magnetic oxygen analyzer and a non-dispersive infra-red
CO2 analyzer, respectively [2900; SensorMedics Corp,
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A 12-lead electrocardiogram was obtained at rest and
every two minutes throughout exercise [Quinton 5000;
Seattle, WA]; heart rate was monitored continuously by
rhythm strip.
Constant Work Rate Exercise Tests (CWR)
At baseline and final visits, subjects performed a constant
work rate (CWR) exercise test at 60% of their maximal
work rate determined from the initial IWR test. The
experimental setup and monitoring for the CWR tests
was identical to the IWR tests.
Subjects arrived at the same time of the day for the
baseline and subsequent two visits. They were given gen-
eral instructions regarding what to eat and/or drink for
breakfast on the day of each study, and reminded to
ingest the same breakfast each time, so as to minimize
variability due to glycemic status and/or time of day. Dur-
ing the endurance exercise test, cumulative oxygen
uptake and carbon dioxide output were tracked. Follow-
ing the test, lactate recovery was measured by earlobe
prick lactate analysis at exhaustion and every 3 minutes
afterwards up to 12 minutes [Accutrend Lactate, Sports
Resource Group, Hawthorne, New York].
When the subject signaled his desire to end the exercise
(time of exhaustion), a button on the computer immedi-
ately converted the work rate to unloaded pedaling (no
resistance) for a recovery period. Endurance was defined
as the duration of the CWR exercise to the point of
fatigue and expressed as total work performed.
Detection of the anaerobic threshold for lactate accu-
mulation by non-invasive gas exchange measurements is
inevitably subject to the possibility of observer error. In
order to overcome this difficulty, we separately coded
each of the sets of gas exchange data and presented them
to two experienced exercise physiologists who were
blinded to the study design. A standardized approach to
interpretation was agreed beforehand by these observers
and has been previously validated [18].
Supplementation Protocol
The proprietary supplement Niteworks®  was manufac-
tured by Herbalife International Inc. (Century City, Cali-
fornia, USA). Each serving contained 5.2 g L-arginine in a
proprietary blend with L-citrulline, 500 mg ascorbic acid,
400IU vitamin E, 400 μg folic acid, 300 mg L-taurine, and
10 mg alpha lipoic acid in a lemon-flavored powder form.
One serving of supplement powder was mixed with 8 oz
of water, administered at bedtime based on the rationale
that nitric oxide levels are lowest during sleep due to
inactivity, lack of food and low blood pressure [19,20].
The placebo group received a powder with all active
ingredients replaced with M-100 maltodextrin.
Blood Tests
Complete blood count, routine chemistry panel, and fast-
ing cholesterol were drawn from the subjects as part of
the screening visit. Reduced and oxidized gluthathione
levels were measured at each visit before and after the
exercise testing in whole blood using the Bioxytech GSH/
GSSG-412 kit from Oxis Research (Portland, OR).
Statistical and Data Analysis
The data was analyzed by one single observer who was
blinded and has had experience obtaining the threshold.
The results were verified by the investigator.
All measurements were summarized using mean, stan-
dard deviation, median, minimum and maximum for
each group at each time point. To summarize changes
using mean and standard deviation for each group and at
e a c h  t i m e  p o i n t ,  p a i r e d  t - t e s t s  w e r e  u s e d  t o  e v a l u a t e
whether change is different from baseline within each
treatment group. Mixed model repeated measures analy-
sis of variance was used to evaluate changes between
groups, and the interaction between changes from base-
line according to group. SAS statistical software, version
9.1 was used to perform all analyses. All tests were two-
sided with significance level 0.05.
Results
Sixteen cyclists were randomized to two arms (n = 8 in
each arm) and all completed the study without any side
effects. There were no significant differences in subject
demographics. The supplementation group had 8 Cauca-
sian and the placebo group consisted of 7 Caucasian and
one African American. The supplementation group's age
ranged from 50 to 62 years with an average age of 57.6
years. The placebo group's age ranged from 50 to73 years
with an average age of 60.6 years. The weight, height,
BMI, blood pressure, resting heart rate, blood count, and
metabolic parameters including cholesterol were not sta-
tistically different between the two groups of subjects.
There were no significant differences in baseline exercise
parameters between the two groups (Table 1) including
anaerobic threshold (2.04 ± 0.26 L/min and 1.89 ± 0.16 L/
min in the placebo and supplemented groups, respec-
tively).
After one week of study, the anaerobic threshold of the
supplement group increased to 2.38 ± 0.18 L/min (an
increase of 0.34 ± 0.061 L/min with a p-value of < 0.01),
while the anaerobic threshold of the control group mar-
ginally changed and was not significant This increase in
anaerobic threshold was preserved at week 3 with an
average increase of 0.29 ± 0.06 L/min in the supplement
group (for a total threshold of 2.33 ± 0.40 L/min), while
there was no change in the control group (p = 0.21).
Therefore, anaerobic threshold in the supplement groupChen et al. Journal of the International Society of Sports Nutrition 2010, 7:13
http://www.jissn.com/content/7/1/13
Page 4 of 7
increased by 16.7% over baseline at week one and 14.2%
over baseline at week three, respectively. (Figure 1, 2 and
Table 2).
We evaluated between group differences for anaerobic
threshold values at each time point. At week 1 (p = 0.01)
and week 3 (p = 0.02), significant between group differ-
ences were observed with supplementation means signif-
icantly higher than anaerobic threshold placebo means.
We observed a significant interaction between group dif-
ferences and change from baseline (p = 0.04). Minimal
differences for power output (measured in watts) over
time compared to baseline and minimal differences
between placebo and supplementation were observed
(interaction p value = 0.12).
While there was not significant change for the control
group, the supplement group had a power output at week
1 of 177.12 ± 21.13 watts as compared with baseline of
154.62 ± 23.21 W. At week three, the increase of power
Table 1: Subject baseline characteristics
Supplementation Placebo
Male 8 8
Race
African American 0 1
Caucasian 8 7
Age (years) mean ± SD 57.6 ± 4.6 60.6 ± 8.7
Height (inches) 70.6 ± 2.1 70.1 ± 1.4
Weight (pounds) 171.0 ± 16.4 170.6 ± 18.3
BMI (kg/m2) 24.1 ± 2.2 24.4 ± 2.9
SBP (mmHg) 111.9 ± 9.2 117.5 ± 9.6
DBP (mmHg) 75.0 ± 7.6 75.6 ± 7.8
Pulse (beats/min) 56.0 ± 6.5 56.0 ± 11.1
Glucose (mg/dL) 77.1 ± 11.7 81.1 ± 19.1
Hgb (g/dL) 14.6 ± 0.8 14.4 ± 0.8
Figure 1 Anaerobic Threshold *p-value < 0.05 between supplemen-
tation and control group.
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output was sustained at 175.27 ± 36.61 W. This translated
to an increase of 22.51 watts at week 1 and 20.66 watts at
week 3 (p-value < 0.01).
The VO2max results are shown in table 2. There was not
any significant change from baseline at neither week 1
nor 3 for either group. Other exercise measurements of
blood pressure recovery, pulse recovery, peak lactate, lac-
tate recovery, were not statistically between the supple-
mented and control groups. There were no changes
observed for oxidized glutathione between the two
groups or over time.
Discussion
The role of nitric oxide in cardiovascular health has been
well described in literature. The effect of nitric oxide on
exercise performance, however, has not been clearly elu-
cida t ed. During a 5 wee k pr ogressive strength training
program, volunteers were given a supplement containing
1 g arginine and 1 g ornithine, or a placebo, each day. The
results suggest that the combination of arginine and orni-
thine taken in conjunction with a high intensity strength
training program can significantly increase muscle
strength and lean body mass [21]. Campbell et al [22]
observed that arginine and α-ketoglutarate positively
influenced 1 RM bench press and Wingate peak power
performance in trained adult men. Arginine was also
reported to improve peak power significantly in non-ath-
lete men [23]. Conversely, a number of studies have failed
to identify any beneficial effect of arginine supplementa-
tion. Liu et al [24] investigated the effect of three day sup-
plementation of 6 gram of arginine on performance in
intermittent exercise in well-trained male college judo
athletes and found the supplementation had no effect on
performance. Similarly, it has been shown that supple-
mentation of arginine aspartate for 14 days prior to mara-
thon run did not affect the subsequent performance in
trained runners [25].
In the present study, we demonstrated a statistically
increase of 16.7% in AT after one week of supplementa-
tion with L-arginine and antioxidants. The observed
increase in AT was further validated by the increase of
22.51 watts of power output at AT. Based on our data, the
supplementation group increased their power output at
threshold. Therefore, these physiological changes should
be associated with prolonged exercise and a higher work
rate due to arginine and antioxidant supplementation.
These data obtained were also remarkable in that every
subject in the supplemented group demonstrated
increases in anaerobic threshold, while none of the sub-
jects in the placebo group demonstrated any increase.
Youthful, healthy, athletic individuals generally have a
healthier NO system, compared with aging, unhealthy,
sedentary individuals [9]. In humans, exercise capacity
declines with advancing age and many individuals lose
the inclination to participate in regular physical activity.
In healthy adults, arginine can be synthesized in suffi-
cient quantities to meet most normal physiological
demands with the rate of de novo synthesis remaining
unaffected by several days of an arginine free diet [26,27].
Our study subjects had an average age >55 years, while
other studies included young athletes [24,25]. This differ-
ence may explain the significant improvement on AT in
our study.
As in other studies [26,28] we did not see an increase in
VO2max, which is defined as the highest value of minute
ventilation attained and measured during incremental
exercise despite the increase in anaerobic threshold. A
possible reason for this lack of increase could be the fact
that VO2max, as its name implies, is also a maximum effort
measurement and, therefore, is effort dependent. By con-
trast, anaerobic threshold is a more sensitive test to mea-
sure changes in exercise performance because it is a
submaximal exercise measure that is not effort-depen-
dent. In a recent review in Journal of Applied Physiology
[28], Saltin stated that VO2max is limited by cardiac out-
put. With the current study design, we would not expect
to see an increase in VO2max because there is no reason
for the cardiac output to increase in these athletes.
Table 2: Anaerobic Threshold and VO2max
AT (L/min) VO2max (L/min)
Supplementation Placebo Supplementation Placebo
Week 0 2.04 ± 0.28 1.88 ± 0.16 3.71 ± 0.34 3.22 ± 0.62
Week 2 2.38 ± 0.18* 1.84 ± 0.18 3.69 ± 0.23 3.26 ± 0.46
Week 3 2.33 ± 0.44* 1.83 ± 0.21 3.72 ± 0.27 3.39 ± 0.47
Mean ± SE, *p-value < 0.05 between baseline and week 1, baseline and week 3Chen et al. Journal of the International Society of Sports Nutrition 2010, 7:13
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It is unclear whether the increase in AT that we
observed in this study was due to L-arginine alone, or a
combination of the nutrients. Pre-treatment with vita-
mins C and E has been shown to block vascular dysfunc-
tion caused by a high-fat and high-sugar diet [29]. L-
arginine, vitamin C, and vitamin E promote a healthy car-
diovascular system by supporting enhanced NO produc-
tion [15]. NO formation is further increased by the
recycling effect of L-citrulline to L-arginine and the fact
that L-citrulline is taken up into cells by a mechanism
independent of that for arginine [30].
This study was performed in trained athletes who were
without any cardiovascular problems. The role of L-argi-
nine supplementation in cardiac patients remains contro-
versial. Furthermore, it is also unclear if arginine
supplementation in the sedentary population can have
the same results. Further research will be needed to
assess the interaction of these factors and to determine
the effects of prolonged administration of arginine and
antioxidants on exercise performance.
Conclusion
An arginine and antioxidant-containing supplement
increased the anaerobic threshold and the work at anaer-
obic threshold at both week one and week three in elderly
cyclists. No effect on VO2max was observed. This study
indicates a potential role of L-arginine and antioxidant
supplementation in improving exercise performance in
elderly.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
SC participated in the design of the study and performed the exercise protocol.
WK performed the exercise testing protocol. SH analyzed blood samples for
glutathione levels. CLC performed statistical analysis. ZL participated in the
design of the study protocol, coordination and draft of the manuscript.
All authors have read and approved the final manuscript.
Acknowledgements
This study was supported by NIH Nutrition and Obesity Training Grant T32 DK 
06788.
Author Details
Center for Human Nutrition, David Geffen School of Medicine at UCLA, Los 
Angeles, CA 90095, USA
References
1. Wu G, Meininger CJ: Regulation of nitric oxide synthesis by dietary 
factors.  Annu Rev Nutr 2002, 22:61-86.
2. Kinlay S, Creager MA, Fukumoto M, Hikita H, Fang JC, Selwyn AP, Ganz P: 
Endothelium-derived nitric oxide regulates arterial elasticity in human 
arteries in vivo.  Hypertension 2001, 38(5):1049-53.
3. Preli RB, Klein KP, Herrington DM: Vascular effects of dietary L-arginine 
supplementation.  Atherosclerosis 2002, 162(1):1-15.
4. Mills TM, Pollock DM, Lewis RW, Branam HS, Wingard CJ: Endothelin-1-
induced vasoconstriction is inhibited during erection in rats.  Am J 
Physiol Regul Integr Comp Physiol 2001, 281(2):R476-R483.
5. Maxwell AJ, Ho HV, Le CQ, Lin PS, Bernstein D, Cooke JP: L-arginine 
enhances aerobic exercise capacity in association with augmented 
nitric oxide production.  J Appl Physiol 2001, 90(3):933-8.
6. Marletta MA, Spiering MM: Trace elements and nitric oxide function.  J 
Nutr 2003, 133(5 Suppl 1):1431S-3S.
7. Rickard NS, Ng KT, Gibbs ME: Further support for nitric oxide-dependent 
memory processing in the day-old chick.  Neurobiol Learn Mem 1998, 
69(1):79-86.
8. Chen L, Majde JA, Krueger JM: Spontaneous sleep in mice with targeted 
disruptions of neuronal or inducible nitric oxide synthase genes.  Brain 
Res 2003, 973(2):214-22.
9. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A, Salvetti A: 
Age-related reduction of NO availability and oxidative stress in 
humans.  Hypertension 2001, 38(2):274-9.
10. Severs NJ: The cardiac muscle cell.  Bioessays 2000, 22(2):188-99.
11. Taddei S, Virdis A, Mattei P, Ghiadoni L, Fasolo CB, Sudano I, Salvetti A: 
Hypertension causes premature aging of endothelial function in 
humans.  Hypertension 1997, 29(3):736-43.
12. Wu G, Meininger CJ: Arginine nutrition and cardiovascular function.  J 
Nutr 2000, 130(11):2626-9.
13. Chauhan A, More RS, Mullins PA, Taylor G, Petch C, Schofield PM: Aging-
associated endothelial dysfunction in humans is reversed by L-
arginine.  J Am Coll Cardiol 1996, 28(7):1796-804.
14. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A: Vitamin C improves 
endothelium-dependent vasodilation by restoring nitric oxide activity 
in essential hypertension.  Circulation 1998, 97(22):2222-9.
15. de NF, Lerman LO, Ignarro SW, Sica G, Lerman A, Palinski W, Ignarro LJ, 
Napoli C: Beneficial effects of antioxidants and L-arginine on oxidation-
sensitive gene expression and endothelial NO synthase activity at sites 
of disturbed shear stress.  Proc Natl Acad Sci USA 2003, 100(3):1420-5.
16. Rodriguez JA, Grau A, Eguinoa E, Nespereira B, Perez-Ilzarbe M, Arias R, 
Belzunce MS, Paramo JA, Martinez-Caro D: Dietary supplementation 
with vitamins C and E prevents downregulation of endothelial NOS 
expression in hypercholesterolemia in vivo and in vitro.  Atherosclerosis 
2002, 165(1):33-40.
17. Buchfuhrer MJ, Hansen JE, Robinson TE, Sue DY, Wasserman K, Whipp BJ: 
Optimizing the exercise protocol for cardiopulmonary assessment.  J 
Appl Physiol 1983, 55(5):1558-64.
18. Braith RW, Graves JE, Leggett SH, Pollock ML: Effect of training on the 
relationship between maximal and submaximal strength.  Med Sci 
Sports Exerc 1993, 25(1):132-8.
19. Guerrero JM, Pablos MI, Ortiz GG, Agapito MT, Reiter RJ: Nocturnal 
decreases in nitric oxide and cyclic GMP contents in the chick brain 
and their prevention by light.  Neurochem Int 1996, 29(4):417-21.
20. Sherwood A, Steffen PR, Blumenthal JA, Kuhn C, Hinderliter AL: Nighttime 
blood pressure dipping: the role of the sympathetic nervous system.  
Am J Hypertens 2002, 15(2 Pt 1):111-8.
21. Elam RP, Hardin DH, Sutton RA, Hagen L: Effects of arginine and 
ornithine on strength, lean body mass and urinary hydroxyproline in 
adult males.  J Sports Med Phys Fitness 1989, 29(1):52-6.
22. Campbell B, Roberts M, Kerksick C, Wilborn C, Marcello B, Taylor L, Nassar E, 
Leutholtz B, Bowden R, Rasmussen C, Greenwood M, Kreider R: 
Pharmacokinetics, safety, and effects on exercise performance of L-
arginine alpha-ketoglutarate in trained adult men.  Nutrition 2006, 
22(9):872-81.
23. Little JP, Forbes SC, Candow DG, Cornish SM, Chilibeck PD: Creatine, 
arginine alpha-ketoglutarate, amino acids, and medium-chain 
triglycerides and endurance and performance.  Int J Sport Nutr Exerc 
Metab 2008, 18(5):493-508.
24. Liu TH, Wu CL, Chiang CW, Lo YW, Tseng HF, Chang CK: No effect of 
short-term arginine supplementation on nitric oxide production, 
metabolism and performance in intermittent exercise in athletes.  J 
Nutr Biochem 2009, 20(6):462-8.
25. Colombani PC, Bitzi R, Frey-Rindova P, Frey W, Arnold M, Langhans W, 
Wenk C: Chronic arginine aspartate supplementation in runners 
reduces total plasma amino acid level at rest and during a marathon 
run.  Eur J Nutr 1999, 38(6):263-70.
26. Castillo L, deRojas TC, Chapman TE, Vogt J, Burke JF, Tannenbaum SR, 
Young VR: Splanchnic metabolism of dietary arginine in relation to 
nitric oxide synthesis in normal adult man.  Proc Natl Acad Sci USA 1993, 
90(1):193-7.
Received: 20 March 2009 Accepted: 23 March 2010 
Published: 23 March 2010
This article is available from: http://www.jissn.com/content/7/1/13 © 2010 Chen et al; licensee BioMed Central Ltd.  This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Journal of the International Society of Sports Nutrition 2010, 7:13Chen et al. Journal of the International Society of Sports Nutrition 2010, 7:13
http://www.jissn.com/content/7/1/13
Page 7 of 7
27. Castillo L, Ajami A, Branch S, Chapman TE, Yu YM, Burke JF, Young VR: 
Plasma arginine kinetics in adult man: response to an arginine-free 
diet.  Metabolism 1994, 43(1):114-22.
28. Saltin B, Calbet JA: Point: in health and in a normoxic environment, VO2 
max is limited primarily by cardiac output and locomotor muscle 
blood flow.  J Appl Physiol 2006, 100(2):744-5.
29. Roberts CK, Vaziri ND, Barnard RJ: Effect of diet and exercise intervention 
on blood pressure, insulin, oxidative stress, and nitric oxide availability.  
Circulation 2002, 106(20):2530-2.
30. Wu G, Morris SM Jr: Arginine metabolism: nitric oxide and beyond.  
Biochem J 1998, 336(Pt 1):1-17.
doi: 10.1186/1550-2783-7-13
Cite this article as: Chen et al., Arginine and antioxidant supplement on per-
formance in elderly male cyclists: a randomized controlled trial Journal of the 
International Society of Sports Nutrition 2010, 7:13